# Active Immunotherapy Of Metastatic Renal Cell Carcinoma Using Autologous Dendritic Cells Transfected With Autologous Total Tumor RNA

> **NCT00006431** · PHASE1 · UNKNOWN · sponsor: **National Center for Research Resources (NCRR)**

## Conditions studied

- Renal Cell Carcinoma

## Interventions

- **BIOLOGICAL:** DC RCC-RNA

## Key facts

- **NCT ID:** NCT00006431
- **Lead sponsor:** National Center for Research Resources (NCRR)
- **Sponsor class:** NIH
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** —
- **Primary completion:** —
- **Final completion:** —
- **Target enrollment:** — (—)
- **Last updated:** 2005-06-24

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00006431

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00006431, "Active Immunotherapy Of Metastatic Renal Cell Carcinoma Using Autologous Dendritic Cells Transfected With Autologous Total Tumor RNA". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT00006431. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*